DocCheck - Public Comps and Valuation Multiples

DocCheck Overview

About DocCheck

DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.

Founded

1990

HQ

Employees

248

Website

doccheck.ag

Sectors

Healthcare Software
Advertising & Marketing
B2B SaaS
Vertical SaaS
Service Providers
HealthTech

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$49.1M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

DocCheck Financials

DocCheck has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, DocCheck achieved revenue of $59.8M and an EBITDA of $10.7M.

DocCheck expects next 12-month revenue of XXX and NTM EBITDA of XXX

See DocCheck valuation multiples based on analyst estimates

DocCheck P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$68.2M	$59.8M	XXX	XXX	XXX
Gross Profit	$48.7M	$42.8M	XXX	XXX	XXX
Gross Margin	71%	72%	XXX	XXX	XXX
EBITDA	$15.0M	$10.7M	XXX	XXX	XXX
EBITDA Margin	22%	18%	XXX	XXX	XXX
Net Profit	$12.8M	$7.0M	XXX	XXX	XXX
Net Margin	19%	12%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

DocCheck Stock Performance

As of May 19, 2025, DocCheck's stock price is EUR 12 (or $13).

DocCheck has current market cap of EUR 59.9M (or $67.0M), and EV of EUR 43.8M (or $49.1M).

See DocCheck trading valuation data

DocCheck Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$49.1M	$67.0M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

DocCheck Valuation Multiples

As of May 19, 2025, DocCheck has market cap of $67.0M and EV of $49.1M.

DocCheck's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate DocCheck's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for DocCheck and 10K+ public comps

DocCheck Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$49.1M	XXX	XXX	XXX
EV/Revenue	0.8x	XXX	XXX	XXX
EV/EBITDA	4.6x	XXX	XXX	XXX
P/E	26.4x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	7.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get DocCheck Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

DocCheck Valuation Multiples

DocCheck's NTM/LTM revenue growth is n/a

DocCheck's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged n/a for the same period.

Over next 12 months, DocCheck's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate DocCheck's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for DocCheck and other 10K+ public comps

DocCheck Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	-12%	XXX	XXX	XXX	XXX
EBITDA Margin	N/A	XXX	XXX	XXX	XXX
EBITDA Growth	-29%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	N/A	XXX	XXX	XXX	XXX
Revenue per Employee	$0.2M	XXX	XXX	XXX	XXX
Opex per Employee	n/a	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	0%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	1%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial